New Frontier for Genomics: Radiotherapy in Early Breast Cancer
April 8th 2020
By individualizing risk of locoregional recurrence and radiosensitivity with molecular subtyping/genomic classifiers, it is hoped that use and/or extent of adjuvant radiation therapy could be tailored in early-stage breast cancer.